Extracorporeal membrane oxygenation is increasingly used in the early postoperative period after lung transplantation to support patients with primary graft dysfunction and severe right ventricular failure, with critical care nurses playing an integral role in ensuring safety and success.
Key Findings
Background
ECMO is increasingly used in the early postoperative period after lung transplantation primarily to support patients with primary graft dysfunction and severe right ventricular failure.
The two main indications for postoperative ECMO are primary graft dysfunction (PGD) and severe right ventricular (RV) failure.
The review synthesizes current evidence on indications for postoperative ECMO in the post-lung transplant setting.
This is described as an area of increasing clinical utilization.
Background
Recipients with high risk, particularly those with pulmonary arterial hypertension, may benefit from prophylactic ECMO to promote controlled reperfusion and reduce early allograft injury.
Prophylactic ECMO is specifically highlighted as potentially beneficial for pulmonary arterial hypertension patients.
The proposed mechanism of benefit is promoting controlled reperfusion.
The intended outcome of prophylactic use is reduction of early allograft injury.
This represents a preventive rather than rescue application of ECMO in the post-transplant context.
Results
Selection between venovenous (VV) and venoarterial (VA) ECMO support should be tailored to the patient's cardiopulmonary physiology.
The review addresses optimal selection between VV and VA configurations.
Cannulation strategies are described as needing to be tailored to cardiopulmonary physiology.
VV ECMO provides respiratory support, while VA ECMO provides both cardiac and respiratory support, making physiological assessment critical to configuration choice.
Results
Key challenges associated with post-lung transplant ECMO include recirculation, vascular complications, infection risk, and altered pharmacokinetics.
Recirculation is identified as a specific technical challenge, particularly relevant to VV configurations.
Vascular complications are cited as a significant risk associated with ECMO cannulation.
Infection risk is identified as a complication requiring active management.
Altered pharmacokinetics during ECMO support is noted as a challenge, likely affecting drug dosing and management.
The review discusses both methods to detect and mitigate each of these challenges.
Background
Critical care nurses play an integral role in ensuring the safety and success of ECMO in post-lung transplant patients.
The review places specific emphasis on the critical care nurse's role.
Nursing responsibilities identified include coordinating multidisciplinary care and identifying complications early.
Nurses are described as applying evidence-based management to support allograft recovery and improve patient outcomes.
The paper is published in AACN Advanced Critical Care, a nursing-focused journal, reflecting the nursing-centered framing of ECMO management.
What This Means
This research review examines how a life-support technology called extracorporeal membrane oxygenation (ECMO) — which pumps and oxygenates blood outside the body — is used in the critical days and weeks after a patient receives a lung transplant. The most common reasons patients need ECMO after lung transplantation are when the new lung does not work well immediately after transplant (called primary graft dysfunction) or when the right side of the heart struggles under the new circulatory demands. The review also highlights that certain high-risk patients, especially those who had pulmonary arterial hypertension before transplant, might benefit from being placed on ECMO before problems even develop, as a way to protect the new lung during the vulnerable early reperfusion period.
The review covers practical clinical decisions, including how to choose between two main types of ECMO — one that supports only the lungs (venovenous) and one that supports both the heart and lungs (venoarterial) — based on each patient's specific condition. It also outlines the complications that can arise during ECMO use, such as blood recirculating without being properly oxygenated, damage to blood vessels, increased infection risk, and changes in how the body processes medications, along with strategies to detect and manage these problems.
This research suggests that ECMO after lung transplantation is a complex but increasingly important tool for helping patients survive the critical early period and giving the new lung time to recover. A particularly notable emphasis of the review is the central role that critical care nurses play in managing ECMO safely — including monitoring for complications, coordinating care among multiple medical teams, and applying the latest evidence-based practices — highlighting nursing as essential to achieving good outcomes for these critically ill patients.
Vo C, Remy A, Moyer E, Gibbs R, Witek S, Crespo M. (2026). Road Map of Extracorporeal Membrane Oxygenation in the Early Post-Lung Transplant Period.. AACN advanced critical care. https://doi.org/10.4037/aacnacc2026592